Cargando…

Does the surgeon still have a role to play in the diagnosis and management of lymphomas?

BACKGROUND: Over the course of the past 40 years, there have been a significant number of changes in the way in which lymphomatous disease is diagnosed and managed. With the advent of computed tomography, there is little role for staging laparotomy and the surgeon's role may now more diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris-Stiff, Gareth, Cheang, Peipei, Key, Steve, Verghese, Anju, Havard, Timothy J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254406/
https://www.ncbi.nlm.nih.gov/pubmed/18248683
http://dx.doi.org/10.1186/1477-7819-6-13
_version_ 1782151181743685632
author Morris-Stiff, Gareth
Cheang, Peipei
Key, Steve
Verghese, Anju
Havard, Timothy J
author_facet Morris-Stiff, Gareth
Cheang, Peipei
Key, Steve
Verghese, Anju
Havard, Timothy J
author_sort Morris-Stiff, Gareth
collection PubMed
description BACKGROUND: Over the course of the past 40 years, there have been a significant number of changes in the way in which lymphomatous disease is diagnosed and managed. With the advent of computed tomography, there is little role for staging laparotomy and the surgeon's role may now more diagnostic than therapeutic. AIMS: To review all cases of lymphoma diagnosed at a single institution in order determine the current role of the surgeon in the diagnosis and management of lymphoma. PATIENTS AND METHODS: Computerized pathology records were reviewed for a five-year period 1996 to 2000 to determine all cases of lymph node biopsy (incisional or excisional) in which tissue was obtained as part of a planned procedure. Cases of incidental lymphadenopathy were thus excluded. RESULTS: A total of 297 biopsies were performed of which 62 (21%) yielded lymphomas. There were 22 females and 40 males with a median age of 58 years (range: 19–84 years). The lymphomas were classified as 80% non-Hodgkin's lymphoma, 18% Hodgkin's lymphoma and 2% post-transplant lymphoproliferative disorder. Diagnosis was established by general surgeons (n = 48), ENT surgeons (n = 9), radiologists (n = 4) and ophthalmic surgeons (n = 1). The distribution of excised lymph nodes was: cervical (n = 23), inguinal (n = 15), axillary (n = 11), intra-abdominal (n = 6), submandibular (n = 2), supraclavicular (n = 2), periorbital (n = 1), parotid (n = 1) and mediastinal (n = 1). Fine needle aspiration cytology had been performed prior to biopsy in only 32 (52%) cases and had suggested: lymphoma (n = 10), reactive changes (n = 13), normal (n = 5), inadequate (n = 4). The majority (78%) of cervical lymph nodes were subjected to FNAC prior to biopsy whilst this was performed in only 36% of non-cervical lymphadenopathy. CONCLUSION: The study has shown that lymphoma is a relatively common cause of surgical lymphadenopathy. Given the limitations of FNAC, all suspicious lymph nodes should be biopsied following FNAC even if the FNAC is reported normal or demonstrating reactive changes only. With the more widespread application of molecular techniques, and the development of improved minimally-invasive procedures, percutaneous and endoscopic techniques may come to dominate, however, at present; the surgeon still has an important role to play in the diagnosis if not treatment of lymphomas.
format Text
id pubmed-2254406
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22544062008-02-26 Does the surgeon still have a role to play in the diagnosis and management of lymphomas? Morris-Stiff, Gareth Cheang, Peipei Key, Steve Verghese, Anju Havard, Timothy J World J Surg Oncol Research BACKGROUND: Over the course of the past 40 years, there have been a significant number of changes in the way in which lymphomatous disease is diagnosed and managed. With the advent of computed tomography, there is little role for staging laparotomy and the surgeon's role may now more diagnostic than therapeutic. AIMS: To review all cases of lymphoma diagnosed at a single institution in order determine the current role of the surgeon in the diagnosis and management of lymphoma. PATIENTS AND METHODS: Computerized pathology records were reviewed for a five-year period 1996 to 2000 to determine all cases of lymph node biopsy (incisional or excisional) in which tissue was obtained as part of a planned procedure. Cases of incidental lymphadenopathy were thus excluded. RESULTS: A total of 297 biopsies were performed of which 62 (21%) yielded lymphomas. There were 22 females and 40 males with a median age of 58 years (range: 19–84 years). The lymphomas were classified as 80% non-Hodgkin's lymphoma, 18% Hodgkin's lymphoma and 2% post-transplant lymphoproliferative disorder. Diagnosis was established by general surgeons (n = 48), ENT surgeons (n = 9), radiologists (n = 4) and ophthalmic surgeons (n = 1). The distribution of excised lymph nodes was: cervical (n = 23), inguinal (n = 15), axillary (n = 11), intra-abdominal (n = 6), submandibular (n = 2), supraclavicular (n = 2), periorbital (n = 1), parotid (n = 1) and mediastinal (n = 1). Fine needle aspiration cytology had been performed prior to biopsy in only 32 (52%) cases and had suggested: lymphoma (n = 10), reactive changes (n = 13), normal (n = 5), inadequate (n = 4). The majority (78%) of cervical lymph nodes were subjected to FNAC prior to biopsy whilst this was performed in only 36% of non-cervical lymphadenopathy. CONCLUSION: The study has shown that lymphoma is a relatively common cause of surgical lymphadenopathy. Given the limitations of FNAC, all suspicious lymph nodes should be biopsied following FNAC even if the FNAC is reported normal or demonstrating reactive changes only. With the more widespread application of molecular techniques, and the development of improved minimally-invasive procedures, percutaneous and endoscopic techniques may come to dominate, however, at present; the surgeon still has an important role to play in the diagnosis if not treatment of lymphomas. BioMed Central 2008-02-04 /pmc/articles/PMC2254406/ /pubmed/18248683 http://dx.doi.org/10.1186/1477-7819-6-13 Text en Copyright © 2008 Morris-Stiff et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Morris-Stiff, Gareth
Cheang, Peipei
Key, Steve
Verghese, Anju
Havard, Timothy J
Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
title Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
title_full Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
title_fullStr Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
title_full_unstemmed Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
title_short Does the surgeon still have a role to play in the diagnosis and management of lymphomas?
title_sort does the surgeon still have a role to play in the diagnosis and management of lymphomas?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254406/
https://www.ncbi.nlm.nih.gov/pubmed/18248683
http://dx.doi.org/10.1186/1477-7819-6-13
work_keys_str_mv AT morrisstiffgareth doesthesurgeonstillhavearoletoplayinthediagnosisandmanagementoflymphomas
AT cheangpeipei doesthesurgeonstillhavearoletoplayinthediagnosisandmanagementoflymphomas
AT keysteve doesthesurgeonstillhavearoletoplayinthediagnosisandmanagementoflymphomas
AT vergheseanju doesthesurgeonstillhavearoletoplayinthediagnosisandmanagementoflymphomas
AT havardtimothyj doesthesurgeonstillhavearoletoplayinthediagnosisandmanagementoflymphomas